Hospital-acquired infections (HAIs) is caused by viral, bacterial, and fungal pathogens which can be dangerous for patients as well as for their companions. To avoid these kind of risks of infection in people that are visiting hospitals, the market for HAIs control has emerged to help in reducing the chances of acquiring more infections. The market for HAIs control is witnessing significant and rapid growth owing to a no. of key developments and market drivers. The global market for HAIs control in 2014 registered revenues worth US$ 50,807 Mn, which are projected to raise up to US$ 82,889.4 Mn by 2020 end. Over the forecast period 2014-2020, the global HAIs control market will expand at a CAGR of 8.5%.
Rising prevalence of HAIs cases, increasing government initiatives expanding awareness about and promoting innovation in anti-HAI technology and procedures, growing demand for improved healthcare facilities, and increasing popularity of cleaning and gas plasma sterilization technology are some of the major drivers contributing to the overall growth of the HAIs control market. However, lack of various healthcare facilities and infrastructure viz. lack of proper supplies, buildings, medical and equipment for communication have hampered the global market for HAIs control. Additionally, lack of awareness and untrained staff in certain developing regions have a negative influence on the growth of global market for HAIs control.
Globally, the prevalence of all the above factors has helped the growth in demand for the HAIs control market. Increasing risk of hospital-acquired infections in hospitals and development of the overall infection control market have formed new market opportunities for the global HAIs control market to grow and improve. Due to lack of training, poor infection control practices in hospitals, increasing geriatric population and people suffering from malnutrition and the consequently decreased levels of immunity, the need for more technical advancements and high focus on improved healthcare facilities has augmented in different regions of the world.
Based on the type, the global HAIs control market is categorized into diagnostic techniques, cleaning and sterilization, and treatment. Among these, the segment of cleaning and sterilization is further categorized into disinfection of linen, instrument sterilization, wide-area sterilization and. Also, the segment of diagnostic techniques is classified into manual testing, automated testing and confirmation testing while the treatment segment is bifurcated as pharmaceutical treatment and environmental treatment. And among these, the pharmaceutical treatment segment is fragmented as viral HAI pharmaceuticals, bacterial HAI pharmaceuticals and fungal HAI pharmaceuticals while the segment of environmental treatment is segmented as air treatment, water treatment and chemical treatment.
Based on geographical region, the global market for HAIs control is segmented into North America, Europe, and Asia. Among these, North America being the largest market dominates the global HAIs market. The U.S. represents the largest market for HAIs control in the North American region. This is due to technical advancements and more focus on improved healthcare facilities in the region. Asia is expected to experience high growth rate in the next five years in HAIs control market. This is due to high prevalence of HAIs in the region and increasing demand for improved healthcare facilities.
Certain trends observed in the global market for HAIs control include rising popularity of technology of gas plasma sterilization. STERIS Corporation, tailed by Getinge AB is a key player in the global HAIs control market. Several other major players in the global market for HAIs control include Advanced Sterilization Products Division, Hoffmann-La Roche Ltd, Pfizer Inc., and Becton Dickinson & Company, among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
